Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Tops Revenue Estimates
FHTX - Free Report) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares...
FHTX - Free Report) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares...